Japan vs Spain: Communicable diseases — Communicable disease incidence
Communicable diseases — Communicable disease incidence over time
- Japan
- Spain
How they compare
Japan currently reports 332 Cases against 299 Cases in Spain, a difference of 33 Cases.
That makes Japan's figure about 1.1 times Spain's.
The two have swapped places 4 times across 39 shared years of data; in 1985 it was Spain ahead.
Japan ranks 11th and Spain ranks 12th of 34 countries.
Spain has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Japan | Spain | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 12 Cases | 1,442 Cases | 1,430 Cases | Spain |
| 1990s | 152.7 Cases | 5,245 Cases | 5,092 Cases | Spain |
| 2000s | 374.3 Cases | 2,051 Cases | 1,677 Cases | Spain |
| 2010s | 431.6 Cases | 779 Cases | 347.4 Cases | Spain |
| 2020s | 300.75 Cases | 315.5 Cases | 14.75 Cases | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher communicable diseases — communicable disease incidence, Japan or Spain?
- Japan, at 332 Cases against 299 Cases in Spain as of 2024.
- What is the difference in communicable diseases — communicable disease incidence between Japan and Spain?
- 33 Cases, with Japan ahead.
- How many years of comparable data are there for Japan and Spain?
- 39 years are reported by both, from 1985 to 2023.
- How do Japan and Spain rank globally for communicable diseases — communicable disease incidence?
- Japan ranks 11th and Spain ranks 12th of 34 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Communicable diseases — Communicable disease incidence. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents time series on Acquired Immunodeficiency Syndrome (AIDS), for the number of AIDS cases and incidence rates per 100 000 population at year of diagnosis. It also includes data on incidence of pertussis, measles, and hepatitis B, in terms of rates of reported cases per 100 000 population. Please refer to the Sources and Methods for detailed country-specific information.